{"log_id": 6064900265965090398, "direction": 0, "words_result_num": 43, "words_result": [{"probability": {"variance": 0.001793, "average": 0.981926, "min": 0.769122}, "location": {"width": 752, "top": 197, "height": 27, "left": 226}, "words": "致癌性:在人类有报道细胞毒药物与第二肿瘤发生风险的增加有关。有文献报道接受甲"}, {"probability": {"variance": 0.029419, "average": 0.891829, "min": 0.385743}, "location": {"width": 749, "top": 229, "height": 29, "left": 227}, "words": "氨蝶呤治疗的患可患淋巴痘包括可性淋和肿瘤溶解综合症。有证据表明使用甲"}, {"probability": {"variance": 0.016201, "average": 0.911458, "min": 0.50068}, "location": {"width": 459, "top": 262, "height": 24, "left": 228}, "words": "氨蝶吟后比动物圳胞和人类骨静细胞染色体玻坏"}, {"probability": {"variance": 0.041018, "average": 0.865649, "min": 0.382418}, "location": {"width": 751, "top": 293, "height": 26, "left": 227}, "words": "感染:曾有报道瘤和肿瘤疾面前按受毕氨蝶吟治疗的患者出现致死性的机会性感"}, {"probability": {"variance": 0.005467, "average": 0.976689, "min": 0.590068}, "location": {"width": 750, "top": 324, "height": 26, "left": 228}, "words": "染。卡氏肺囊虫性肺炎是最常的一种感染。其它报道的感染包括肺炎、败血症、诺卡"}, {"probability": {"variance": 0.006853, "average": 0.96862, "min": 0.534745}, "location": {"width": 730, "top": 354, "height": 27, "left": 227}, "words": "氏菌病、组织胞浆菌病、隐球菌病、带状疱疹、单纯疱疹病毒性炎、弥散性单纯疱疹"}, {"probability": {"variance": 0.0087, "average": 0.940692, "min": 0.647867}, "location": {"width": 444, "top": 385, "height": 26, "left": 227}, "words": "致死性败血症和巨细胞病母包括巨细胞病毒性肺炎"}, {"probability": {"variance": 0.005894, "average": 0.966507, "min": 0.577011}, "location": {"width": 752, "top": 415, "height": 30, "left": 226}, "words": "其它:其它曾报道与使用甲氨蝶呤相关的或出甲氨蝶呤引起的反应有代谢改变、糖尿病"}, {"probability": {"variance": 0.001341, "average": 0.977223, "min": 0.847069}, "location": {"width": 730, "top": 447, "height": 30, "left": 228}, "words": "加重、骨质疏松(包括股骨头无菌性坏死)、组织细胞异常改变、关节痛肌痛、蛋白尿"}, {"probability": {"variance": 0.025891, "average": 0.92983, "min": 0.355216}, "location": {"width": 423, "top": 478, "height": 26, "left": 227}, "words": "结节病、应力性骨折、性欲诚弱、痿甚至猝死"}, {"probability": {"variance": 5e-06, "average": 0.996707, "min": 0.994001}, "location": {"width": 101, "top": 539, "height": 25, "left": 200}, "words": "【禁忌】"}, {"probability": {"variance": 0.002312, "average": 0.968662, "min": 0.86214}, "location": {"width": 240, "top": 571, "height": 24, "left": 195}, "words": "有以下情况时禁用甲氨蝶呤"}, {"probability": {"variance": 0.034741, "average": 0.923577, "min": 0.430716}, "location": {"width": 151, "top": 602, "height": 24, "left": 233}, "words": "患银屑病的孕:"}, {"probability": {"variance": 0.001453, "average": 0.973686, "min": 0.901075}, "location": {"width": 104, "top": 632, "height": 26, "left": 233}, "words": "哺乳期妇女"}, {"probability": {"variance": 0.000322, "average": 0.987381, "min": 0.94594}, "location": {"width": 283, "top": 663, "height": 27, "left": 235}, "words": "有严重肝功能不全的银屑病患者"}, {"probability": {"variance": 0.001366, "average": 0.982922, "min": 0.872603}, "location": {"width": 225, "top": 695, "height": 25, "left": 234}, "words": "有严重肾功能不全的海者"}, {"probability": {"variance": 0.04408, "average": 0.866252, "min": 0.416949}, "location": {"width": 343, "top": 727, "height": 23, "left": 234}, "words": "有酒精中或酒精性屏病的银屑病患者"}, {"probability": {"variance": 0.016435, "average": 0.932173, "min": 0.563501}, "location": {"width": 387, "top": 757, "height": 25, "left": 233}, "words": "有明显的或实验室检查证实的免疫缺患者"}, {"probability": {"variance": 0.027261, "average": 0.906003, "min": 0.350774}, "location": {"width": 746, "top": 786, "height": 31, "left": 234}, "words": "有骨髓抑制或已存在血恶液质的病患者,如骨髓发育不全、白细胞减少、血小板减"}, {"probability": {"variance": 2.3e-05, "average": 0.996404, "min": 0.988318}, "location": {"width": 83, "top": 819, "height": 23, "left": 234}, "words": "少或贫血"}, {"probability": {"variance": 0.004323, "average": 0.964185, "min": 0.776408}, "location": {"width": 245, "top": 850, "height": 23, "left": 235}, "words": "存在严重感染的银屑病患者"}, {"probability": {"variance": 0.037919, "average": 0.871309, "min": 0.369749}, "location": {"width": 343, "top": 881, "height": 24, "left": 235}, "words": "已知对甲氨呤或任何辅料过敏的患者"}, {"probability": {"variance": 0.00286, "average": 0.975031, "min": 0.781087}, "location": {"width": 404, "top": 913, "height": 24, "left": 233}, "words": "有消化性溃疡病或溃疡性结肠炎的银屑病患者"}, {"probability": {"variance": 0.003538, "average": 0.974056, "min": 0.763869}, "location": {"width": 539, "top": 943, "height": 26, "left": 234}, "words": "接受中枢神经系统放疗的患者不应同时接受甲氨蝶昤鞘内注射"}, {"probability": {"variance": 2e-06, "average": 0.997787, "min": 0.996263}, "location": {"width": 42, "top": 1005, "height": 23, "left": 194}, "words": "警告"}, {"probability": {"variance": 0.004829, "average": 0.975075, "min": 0.706073}, "location": {"width": 739, "top": 1035, "height": 32, "left": 241}, "words": "甲氨蝶呤只能由有抗代谢药物化疗经验的内科医生使用、如果是非肿瘤的情况则必须"}, {"probability": {"variance": 6e-06, "average": 0.998104, "min": 0.993514}, "location": {"width": 204, "top": 1067, "height": 24, "left": 194}, "words": "由专业的内科医生使用"}, {"probability": {"variance": 0.008022, "average": 0.96927, "min": 0.578457}, "location": {"width": 740, "top": 1099, "height": 27, "left": 239}, "words": "因为有致命或严重的毒性反应的可能,内科医生必须充分告知患者存在的风险,并且"}, {"probability": {"variance": 0.000226, "average": 0.992348, "min": 0.951241}, "location": {"width": 182, "top": 1130, "height": 23, "left": 194}, "words": "应该在其监督下用药"}, {"probability": {"variance": 0.004033, "average": 0.979968, "min": 0.760131}, "location": {"width": 264, "top": 1161, "height": 24, "left": 235}, "words": "有使用甲氨蝶呤后死亡的报道"}, {"probability": {"variance": 0.027183, "average": 0.912157, "min": 0.437653}, "location": {"width": 742, "top": 1187, "height": 32, "left": 234}, "words": "在治疗银屑病时甲氨蝶岭仅限用下对它治疗方式效不显的严重、顽周和致残性病"}, {"probability": {"variance": 0.038303, "average": 0.897694, "min": 0.390536}, "location": {"width": 556, "top": 1219, "height": 31, "left": 194}, "words": "例、并且只能在维织活检或适当会诊明确诊断后使用。"}, {"probability": {"variance": 0.03942, "average": 0.880648, "min": 0.38117}, "location": {"width": 416, "top": 1252, "height": 25, "left": 195}, "words": "1.甲氨蝶吟可以引起显著的骨抑制、货"}, {"probability": {"variance": 0.000678, "average": 0.988952, "min": 0.897616}, "location": {"width": 288, "top": 1254, "height": 25, "left": 691}, "words": "性贫血、白细胞减少、中性粒细"}, {"probability": {"variance": 0.000114, "average": 0.99336, "min": 0.96159}, "location": {"width": 241, "top": 1284, "height": 24, "left": 251}, "words": "胞减少、血小板减少和血"}, {"probability": {"variance": 0.015122, "average": 0.933351, "min": 0.398855}, "location": {"width": 785, "top": 1325, "height": 26, "left": 195}, "words": "2.甲氨蝶吟可能具有脏毒性,特别建在大剂或长时间治疗的情况下。曾报道有肝萎"}, {"probability": {"variance": 0.020214, "average": 0.936319, "min": 0.47096}, "location": {"width": 730, "top": 1356, "height": 26, "left": 249}, "words": "缩、肝坏死、肝硬化、脂肪变性和门静脉周周纤维化。山干这些反应可以在没有胃肠"}, {"probability": {"variance": 0.001921, "average": 0.982529, "min": 0.808553}, "location": {"width": 724, "top": 1385, "height": 29, "left": 250}, "words": "道或血液学毒性的预兆下发生,所以必须在治疗开始前评估肝功能,并且在治疗的过"}, {"probability": {"variance": 0.002033, "average": 0.984847, "min": 0.727842}, "location": {"width": 728, "top": 1417, "height": 26, "left": 251}, "words": "程中定期监测。在已有肝细胞损害或肝功能受损的情况下要特别注意。必须避免同时"}, {"probability": {"variance": 0.002983, "average": 0.973652, "min": 0.777621}, "location": {"width": 392, "top": 1448, "height": 25, "left": 252}, "words": "使用其它有潜在肝脏都性的药物(包括酒精)"}, {"probability": {"variance": 0.006476, "average": 0.959798, "min": 0.639197}, "location": {"width": 785, "top": 1489, "height": 28, "left": 195}, "words": "3.甲氨蝶呤停药后恶性淋巴瘤可能消退,上述情况可发生在接受低剂量甲氨蝶呤治疗的"}, {"probability": {"variance": 0.020756, "average": 0.929715, "min": 0.461941}, "location": {"width": 727, "top": 1521, "height": 27, "left": 251}, "words": "思者中,这些患者可能不需要细胞毒药物治疗,应首先停止使用甲氨蝶呤,如果淋巴"}, {"probability": {"variance": 0.00181, "average": 0.983309, "min": 0.832564}, "location": {"width": 302, "top": 1553, "height": 24, "left": 250}, "words": "瘤没有消退须制定适当的疗方案"}], "language": 3}